We’re supported by referral fees from advertisers on this site.

BestNADTreatments
Updated on

He & She MD vs RenuviaRX: NAD+ Therapy Compared

He & She MD starts at $149/mo (12-month supply) and offers injection, topical cream & nasal spray, while RenuviaRX starts at $179 to start with injection. Below we line them up on price, delivery formats, dosing, shipping, and overall value so you can see which prescription NAD+ provider fits you best.

  • Physician-Prescribed Only
  • 22 Providers Compared
  • Results in 2–4 Weeks
← All NAD+ comparisons
Our #1 pick
He & She MD logo

He & She MD

9.90

Our #1 NAD+ pick — three formats (injection, cream, and nasal spray) at one flat $149/mo. No membership, no hidden fees, free shipping.

Visit He & She MD
VS
Our #10 pick
RenuviaRX logo

RenuviaRX

9.55

Just $179 to start • No insurance needed + free shipping

Visit RenuviaRX
FeatureHe & She MDRenuviaRX
Editorial score9.90 / 109.55 / 10
Starting price$149/mo (12-month supply)$179 to start
Renewal / ongoingFlat $149/mo across every format$249/mo
Delivery formatsInjection, topical cream & nasal sprayInjection
Dose strengthsSupplied as a 12-month coursePer physician protocol
ShippingFree expeditedFree
Membership / feesNone — no membership costNone
Guarantee
Best forPeople who want a choice of injection, cream, or nasal spray at one flat, transparent price with included ongoing carePeople who want a board-certified physician to design their NAD+ protocol for both anti-aging skin benefits and improved energy and mental clarity.

Where He & She MD stands out

  • + Lower entry price — $149/mo (12-month supply)
  • + More delivery formats — injection, topical cream & nasal spray
  • + Higher editorial score (9.90 vs 9.55)

Where RenuviaRX stands out

RenuviaRX is closely matched with He & She MD on the headline metrics — the deciding factors come down to delivery format and the specifics below.

Pros & cons, side by side

He & She MD

Pros

  • + Three delivery formats — injection, topical cream, and nasal spray
  • + Two needle-free options (cream and nasal spray), rare in this market
  • + One flat $149/mo price across every format
  • + No membership cost and no hidden fees
  • + Board-certified providers and FDA-regulated dispensing pharmacies
  • + Unlimited provider messaging for ongoing care

Cons

  • Compounded NAD+ — not an FDA-approved finished drug product
  • The $149/mo rate is tied to a 12-month supply commitment

RenuviaRX

Pros

  • + Board-certified physicians customize every treatment plan
  • + Targets cellular skin repair alongside energy and mental clarity
  • + No insurance needed — straightforward $179 starting price
  • + Free shipping included on every order
  • + Comprehensive approach: look younger and feel younger

Cons

  • Newer platform with a smaller patient base than legacy providers
  • Injection-only — no nasal or oral option

The verdict: He & She MD vs RenuviaRX

In our editorial ranking, He & She MD places higher (#1 vs #10), making it the default pick for most readers — it's best for people who want a choice of injection, cream, or nasal spray at one flat, transparent price with included ongoing care. That said, RenuviaRX is the stronger choice for people who want a board-certified physician to design their NAD+ protocol for both anti-aging skin benefits and improved energy and mental clarity.. Both are prescription NAD+ services, so the right answer depends on the delivery format and price structure that match how you want to start.

Pricing and product details were verified against each provider's official pages and may change — always confirm current terms on the provider's site. Rx required; a licensed provider determines whether NAD+ therapy is appropriate for you. We may earn a commission from links on this page, which never affects our rankings.

Medical disclaimer: This page is for informational purposes only and is not medical advice. Always consult a licensed healthcare provider before starting any NAD+ therapy. We may earn a commission from partner links on this page — see our affiliate disclosure.